mRNA in the context of protein replacement therapy

T Vavilis, E Stamoula, A Ainatzoglou, A Sachinidis… - Pharmaceutics, 2023 - mdpi.com
Protein replacement therapy is an umbrella term used for medical treatments that aim to
substitute or replenish specific protein deficiencies that result either from the protein being …

The COVID Emergency as Autoimmune Disease

C Gundermann - Catalyst: Feminism, Theory, Technoscience, 2024 - catalystjournal.org
This article analyzes the United States biosecurity state's orchestration of the COVID-19
phenomenon into a public health emergency, tracing the legal platforms that made this …

Evaluation of anti-spike glycoprotein antibody and neutralizing antibody response of different vaccine platforms. A protocol of systematic review and meta-analysis of …

M Mirzakhani, S Tahmasebi, M Dashti… - medRxiv, 2022 - medrxiv.org
Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged
in late 2019 and spread globally, prompting an international effort to accelerate …

mRNA Covid-19 Pharmaceuticals and the Spike Antigen

S Mueller - Challenges and Opportunities of mRNA Vaccines …, 2022 - Springer
mRNA Covid-19 Pharmaceuticals and the Spike Antigen | SpringerLink Skip to main content
Advertisement SpringerLink Account Menu Find a journal Publish with us Track your research …

[引用][C] dsRNA dependent protein kinase (PKR) and pseudouridine

M Turkia